Interest of the SPECT-CT Scan SUVspect in the New Generation of Gamma-cameras With Semiconductor

Launched by LILLE CATHOLIC UNIVERSITY · Jan 23, 2018

Keywords

ClinConnect Summary

This clinical trial is studying a new type of gamma-camera that uses advanced technology to improve how doctors can assess various medical conditions, including those affecting the thyroid, heart, bones, brain, and kidneys. This camera can measure the amount of a radioactive substance (called a tracer) in specific areas of the body without requiring additional injections or exposing patients to extra radiation. By using this technology, doctors hope to gain better insights into the distribution of the tracer, which can help refine the interpretation of the results from nuclear medicine tests.

To be eligible for this trial, participants need to be adults who have been referred to the nuclear medicine department for a specific type of imaging test using a tracer. It's important to note that those who refuse to participate or are under guardianship cannot join the study. Patients can expect to undergo their usual imaging tests, but with the added benefit of using this new gamma-camera that may provide more detailed information to help their doctors make more informed decisions about their care. This trial is currently looking for participants, and it is significant because it represents a new approach in nuclear medicine that could enhance patient assessments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - informed adult patients referred to our department of nuclear medicine for a nuclear medicine exploration
• Exclusion Criteria:
• • Refusal to participate
• • Patient under guardianship